Previous Close | 16.33 |
1-Year Change | -33.18% |
6-Months Change | -12.49% |
3-Months Change | 10.71% |
Moving Avg (50d) | 16.873 |
Moving Avg (200d) | 20.014 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.68M |
Beta (3-Years) | 1.02 |
Revenue Growth (ttm) | 23.54% |
Net Profit Margin (ttm) | -23.55% |
Return On Assets (ttm) | -23.53% |
EPS (ttm) | -648.43 |
PE Ratio (ttm) | -0.03 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia